Tvardi Therapeutics

Contributing Author

Recent Articles by Tvardi Therapeutics

Apr-02	Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium TVRD GlobeNewswire
Mar-31	Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update TVRD -5.66% TVRD GlobeNewswire
Feb-12	Tvardi Therapeutics to Participate in Upcoming Investor Conferences TVRD GlobeNewswire
Jan-08	Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference TVRD +8.74% TVRD +7.57% GlobeNewswire
Jan-08	Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights TVRD +8.74% GlobeNewswire